Head to Head Survey: Vasamed (OTCMKTS:VSMD) vs. LivaNova (NASDAQ:LIVN)

LivaNova (NASDAQ:LIVN) and Vasamed (OTCMKTS:VSMD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Earnings & Valuation

This table compares LivaNova and Vasamed”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39 billion	3.13	-$242.47 million	$1.95	40.62
Vasamed	N/A	N/A	N/A	N/A	N/A

Vasamed has lower revenue, but higher earnings than LivaNova.

Analyst Ratings

This is a breakdown of current ratings for LivaNova and Vasamed, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0	4	6	0	2.60
Vasamed	0	0	0	0	0.00

LivaNova currently has a consensus price target of $81.38, indicating a potential upside of 2.73%. Given LivaNova’s stronger consensus rating and higher probable upside, analysts clearly believe LivaNova is more favorable than Vasamed.

Institutional and Insider Ownership

97.6% of LivaNova shares are owned by institutional investors. 0.3% of LivaNova shares are owned by insiders. Comparatively, 8.0% of Vasamed shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares LivaNova and Vasamed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
Vasamed	N/A	N/A	N/A

Summary

LivaNova beats Vasamed on 8 of the 9 factors compared between the two stocks.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

About Vasamed

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system. It serves clinicians and patients. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota.